Orca Bio

Medical Science Liaison

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Position Overview

  • Location Type: Remote (with frequent travel up to 50%, including occasional evenings and weekends)
  • Employment Type: Regular, Full-Time Employee
  • Salary: Not specified
  • Brief Description: Orca Bio is a biotechnology company developing next-generation cell therapies for blood cancer. The Medical Science Liaison (MSL) will build relationships with key opinion leaders (KOLs) and support the company's scientific and clinical strategy. This role requires strong scientific knowledge and the ability to travel frequently.

Requirements

  • Strong scientific background in hematology, oncology, or related field.
  • Deep understanding of blood cancers, stem cell transplantation, and cell therapies.
  • Ability to develop and maintain strong, scientific relationships with KOLs.
  • Excellent communication and presentation skills.
  • Ability to travel up to 50% of the time, including occasional evenings and weekends.

Responsibilities

  • Identify, develop, and maintain strong, scientific, peer-to-peer relationships with academic and community research thought leaders, appropriate HCPs, and access stakeholders within a given geography.
  • Prepare and maintain a territory management plan.
  • Engage with Orca Pod field team members to provide medical support.
  • Develop and maintain an advanced level of knowledge about pertinent studies, compounds, and diseases.
  • Engage in meaningful and compliant scientific exchange with thought leaders, ensuring patients have access to Orca Bio medicines.
  • Actively assess the medical landscape by meeting with TL/HCPs to understand their viewpoint on research and science.

Application Instructions

  • Not specified in the provided text.

Company Information

  • Company: Orca Bio
  • Industry: Biotechnology
  • Mission: To redefine the transplant process by developing next-generation cell therapies, aiming for significantly better survival rates with dramatically fewer risks.
  • Focus: Developing purified, high-precision investigational cell therapies for blood cancer.

Skills

Scientific knowledge in hematology
Oncology
Blood cancers
Stem cell transplantation
Cell therapies
Relationship building with KOLs
Communication skills
Presentation skills
Travel management

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI